Patent · US Active

Treatments for resistant acne

US11045479B2 · kind B2 · utility

0Cited by
4References
28Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 18, 2018
Grant dateJun 29, 2021
Priority date
Expiry dateJul 18, 2038

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates generally to novel molecules, compositions, and formulations for treatment of bacterial infections in general and more specifically to bacterial infections with antibiotic resistant pathogens.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.